Human Microbiome Market

Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025

Report Code: BT 2711 Mar, 2017, by marketsandmarkets.com

[148 Pages Report] The global human microbiome market is estimated to reach USD 899.1 Million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025). Rising aging population, increasing incidences of lifestyle diseases, gradual demand for efficient and safe medication with no side effects, and treatment of diseases having a limited success rate are driving the growth of the global market. The market is an emerging market with abundant opportunities and is expected to flourish within five to seven years owing to a number of products currently under the clinical trial phase. In this report, the global market is divided into three major segments namely, application, disease, and product.

The products segment is further classified into: probiotics, prebiotics, food, medical foods, devices, drugs and other probiotic supplements. The probiotics segment is expected to account for the largest share in the market. The large share of this segment can be attributed to the growing adoption of probiotic products.

The disease segment is also further categorized into: obesity, diabetes, autoimmune disorder, cancer, acute diarrhea, mental disorder and other diseases (cardiovascular, metabolic syndrome (elevated blood lipids, high bp, and liver diseases), drug metabolism, and atopic dermatitis). Acute diarrhea is expected to account for the largest share of the market. Factors such as rising prevalence of communicable diseases, growing awareness among patients regarding the use of microbiome-based products, and technological advancements will stimulate the growth of this segment in the human microbiome disease market.

The factors restraining the market include lack of comprehensive research to assist in market pull, lack of awareness among the population regarding the efficient usage and effect of prebiotics and probiotics, and impending government regulations on probiotics and prebiotics.

Europe is expected to command as a resourceful market with the largest share in the market and expected to grow within the coming years. This is due to Europe’s aging population size and the increasing lifestyle diseases, followed by the increasing need to stay fit and have a healthy lifestyle has leveraged the use of prebiotics and probiotics. APAC accounted for the second-largest market share and will be the main focus of the market in the coming five years that will register high-growth rates for all the segments.

The key players in the human microbiome market are Enterome Bioscience (France), Yakult (Japan), DuPont (U.S.), Metabiomics Corporation (U.S.), and ViThera Pharmaceuticals (U.S.)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

The research report categorizes the human microbiome market into the following segments and subsegments:

Human Microbiome Market, by Product

  • Probiotics
  • Prebiotics
  • Food
  • Medical Foods
  • Devices
  • Drugs
  • Other Probiotic supplements

By Application

  • Therapeutics
  • Diagnostics

By Disease

  • Obesity
  • Diabetes
  • Autoimmune Disorder
  • Cancer
  • Acute Diarrhea
  • Mental Disorder
  • Other (Cardiovascular, Metabolic Syndrome (Elevated Blood Lipids, High Bp, and Liver Diseases), Drug Metabolism, and Atopic Dermatitis)

Human Microbiome Research Spending Market, by Product

  • Instruments
  • Laboratory Instruments
  • Analyzers
  • Consumables
  • Kits
  • Reagents

Human Microbiome Research Spending Market, by Technology

  • Omics Technology
  • High-throughput Technology
  • Cell Culture Technology
  • Computational Tools

By Region

  • North America
    • U.S.
    • Canada
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of Europe and Asia-Pacific Human market into Japan, China, India, South Korea and other countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The human microbiome market is segmented into application, disease, product, and region while the human microbiome research spending market is broadly segmented into product and technology.

The market is expected to reach USD 899.11 million by 2025 from USD 506.48 million in 2022, at a CAGR of 22.1% from 2020 to 2023. The human microbiome research spending market is expected to reach USD 800.8 million by 2020 from USD 423.3 million in 2015, at a CAGR of 13.6% from 2015 to 2020. The market is driven by the increasing prevalence of chronic and lifestyle diseases; augmented awareness and acceptance of prebiotics, probiotics, and medical foods; ongoing research activities; and advancements in molecular diagnostic techniques. However, persistent regulatory issues and approval concerns for microbiome-based products may curb the growth of this market. However, government regulation and lack of detailed research may restrain the growth of this market to an extent.

Based on disease, the market is categorized into obesity, diabetes, autoimmune disorders, cancer, acute diarrhea, mental disorders, and other diseases such as cardiovascular diseases, other immune disorders (irritable bowel syndrome), metabolic syndrome (elevated blood lipids, high BP, and liver diseases), other mental disorders (bipolar disorders, schizophrenia, and drug metabolism), and atopic dermatitis. Acute diarrhea is expected to account for the largest share of the market in 2022. Factors such as rising prevalence of communicable diseases, growing awareness among patients regarding the use of microbiome-based products, and technological advancements will stimulate the growth of this segment in the human microbiome disease market.

The human microbiome research spending market, by technology, is divided into cell culture technology, high-throughput technology, omics technology, and computational tools. The cell culture technology is the most widely-used technology in microbiome research, and is expected to account for the largest share of the human microbiome research spending market in 2016. The large share of this segment can be attributed to its usage in the in vitro model to reproduce in vivo conditions and to study host-microbial community interactions.

Europe is expected to dominate the market with a share of in 2022. It is the prime market for microbiome companies due to the huge awareness and acceptance of microbiome-based products, rising incidences of chronic and lifestyle diseases, and high awareness of pharmacogenomics/personalized medicine in this region. In addition, major local companies have easy access to this market, which makes Europe the largest and most significant market for suppliers.

The key players in the human microbiome market are Enterome Bioscience (France), Yakult Honsha Co., Ltd. (Japan), E. I. Du Pont de Nemours and Company (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome, Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences, Inc. (U.S.), Osel, Inc. (U.S.), and Merck & Co, Inc. (U.S.)

Human Microbiome Market

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Approach
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Key Industry Insights
           2.3.4 Assumptions

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 30)
    4.1 Market Overview
    4.2 Global Market, By Product (2022)
    4.3 Geographic Growth Opportunities
    4.4 Geographic Mix
    4.5 Developing vs Developed Regions
    4.6 Global Research Spending Market, By Technology

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increased Focus on Human Microbiome Therapy
                    5.2.1.2 Human Microbiome as New Validated Target for Drug Development
                    5.2.1.3 Human Microbiome for Early Disease Detection and Diagnosis
           5.2.2 Restraints
                    5.2.2.1 Lack of Expertise and Detailed Research
                    5.2.2.2 Barriers in Proving the Causal Link Between Dysbiosis and Disease
           5.2.3 Opportunities
                    5.2.3.1 Investigational New Drug (IND) Requirements for Fecal Microbiota
                    5.2.3.2 Increasing Collaborations Create Growth Opportunities
           5.2.4 Challenge
                    5.2.4.1 Government Regulations
           5.2.5 Burning Issues
                    5.2.5.1 Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments
                    5.2.5.2 Development of Human Microbiome Therapeutic Products
    5.3 Patents
    5.4 Funding

6 Human Microbiome Market, By Product (Page No. - 43)
    6.1 Introduction
    6.2 Probiotics
    6.3 Foods
    6.4 Prebiotics
    6.5 Medical Foods
    6.6 Diagnostic Devices
    6.7 Drugs
    6.8 Other Probiotic Supplements

7 By Application (Page No. - 52)
    7.1 Introduction
    7.2 Therapeutics
    7.3 Diagnostics

8 By Disease (Page No. - 56)
    8.1 Introduction
    8.2 Acute Diarrhea
    8.3 Obesity
    8.4 Diabetes
    8.5 Autoimmune Disorders
    8.6 Cancer
    8.7 Mental Disorders
    8.8 Other Diseases

9 Human Microbiome Research Spending Market, By Product (Page No. - 65)
    9.1 Introduction
    9.2 Instruments
           9.2.1 Laboratory Instruments
           9.2.2 Analyzers
    9.3 Consumables
           9.3.1 Kits
           9.3.2 Reagents

10 Human Microbiome Research Spending Market, By Technology (Page No. - 74)
     10.1 Introduction
     10.2 Cell Culture Technology
     10.3 High-Throughput Technology
     10.4 Omics Technology
     10.5 Computational Tools

11 By Region (Page No. - 80)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
     11.4 Asia-Pacific
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 107)
     12.1 Overview
     12.2 Competitive Situation and Trends
             12.2.1 Agreements, Partnerships, and Collaborations
             12.2.2 Expansions
             12.2.3 Product Launches and Approvals
             12.2.4 Other Developments

13 Company Profiles (Page No. - 112)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     13.1 Enterome Bioscience
     13.2 E.I. Du Pont De Nemours and Company
     13.3 Merck & Co., Inc.
     13.4 Metabiomics Corporation
     13.5 Yakult Honsha Co., Ltd.
     13.6 Microbiome Therapeutics, LLC
     13.7 Osel, Inc.
     13.8 Second Genome, Inc.
     13.9 Vithera Pharmaceuticals
     13.10 Vedanta Biosciences, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 134)
     14.1 Insights From Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports
     14.8 Author Details


List of Tables (91 Tables)

Table 1 By Product, 2022–2025 (USD Million)
Table 2 Market Size for Probiotics, By Region, 2022-2025 (USD Million)
Table 3 Market for Foods, By Region, 2022-2025 (USD Million)
Table 4 Human Microbiome Market Size for Prebiotics, By Region, 2022-2025 (USD Million)
Table 5 Market Size for Medical Foods, By Region, 2022-2025 (USD Million)
Table 6 Market Size for Diagnostic Devices, By Region, 2020–2025 (USD Million)
Table 7 Market Size for Drugs, By Region, 2022–2025 (USD Million)
Table 8 Human Microbiome Market Size for Other Probiotic Supplements, By Region, 2022-2025 (USD Million)
Table 9 Market Size, By Application, 2022–2025 (USD Million)
Table 10 Market Size for Therapeutic Applications, By Region, 2022–2025 (USD Million)
Table 11 Market Size for Diagnostic Applications, By Region, 2021–2025 (USD Million)
Table 12 Market Size, By Disease, 2022–2025 (USD Million)
Table 13 Market Size for Acute Diarrhea, By Region, 2022–2025 (USD Million)
Table 14 Market Size for Obesity, By Region, 2021–2025 (USD Million)
Table 15 Market Size for Diabetes, By Region, 2022–2025 (USD Million)
Table 16 Market Size for Autoimmune Disorders, By Region, 2021–2025 (USD Million)
Table 17 Human Microbiome Market Size for Cancer, By Region, 2022–2025 (USD Million)
Table 18 Market Size for Mental Disorders, By Region, 2022–2025 (USD Million)
Table 19 Human Microbiome Market Size for Other Diseases, By Region, 2021–2025 (USD Million)
Table 20 Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 21 Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 22 Research Spending Market Size for Instruments, By Region, 2014–2021 (USD Million)
Table 23 North America: Research Spending Market Size for Instruments, By Country, 2014–2021 (USD Million)
Table 24 Human Microbiome Research Spending Market Size for Laboratory Instruments, By Region, 2014–2021 (USD Million)
Table 25 North America: Research Spending Market Size for Laboratory Instruments, By Country, 2014–2021 (USD Million)
Table 26 Human Microbiome Research Spending Market Size for Analyzers, By Region, 2014–2021 (USD Million)
Table 27 North America: Research Spending Market Size for Analyzers, By Country, 2014–2021 (USD Million)
Table 28 Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 29 Human Microbiome Research Spending Market Size for Consumables, By Region, 2014–2021 (USD Million)
Table 30 North America: Research Spending Market Size for Consumables, By Country, 2014–2021 (USD Million)
Table 31 Human Microbiome Research Spending Market Size for Kits, By Region, 2014–2021 (USD Million)
Table 32 North America: Research Spending Market Size for Kits, By Country, 2014–2021 (USD Million)
Table 33 Human Microbiome Research Spending Market Size for Reagents, By Region, 2014–2021 (USD Million)
Table 34 North America: Human Microbiome Research Spending Market Size for Reagents, By Country, 2014–2021 (USD Million)
Table 35 Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 36 Human Microbiome Research Spending Market Size for Cell Culture Technology, By Region, 2014–2021 (USD Million)
Table 37 North America: Research Spending Market Size for Cell Culture Technology, By Country, 2014–2021 (USD Million)
Table 38 Human Microbiome Research Spending Market Size for High-Throughput Technology, By Region, 2014–2021 (USD Million)
Table 39 North America: Research Spending Market Size for High-Throughput Technology, By Country, 2014–2021 (USD Million)
Table 40 Human Microbiome Research Spending Market Size for Omics Technology, By Region, 2014–2021 (USD Million)
Table 41 North America: Research Spending Market Size for Omics Technology, By Country, 2014–2021 (USD Million)
Table 42 Human Microbiome Research Spending Market Size for Computational Tools, By Region, 2014–2021 (USD Million)
Table 43 North America: Human Microbiome Research Spending Market Size for Computational Tools, By Country, 2014–2021 (USD Million)
Table 44 Human Microbiome Market Size, By Region, 2022–2025 (USD Million)
Table 45 Human Microbiome Research Spending Market Size, By Region, 2014–2021 (USD Million)
Table 46 North America: Market Size, By Product, 2022–2025 (USD Million)
Table 47 North America: Market Size, By Application, 2022–2025 (USD Million)
Table 48 North America: Market Size, By Disease, 2022–2025 (USD Million)
Table 49 North America: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 50 North America: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 51 North America: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 52 North America: Human Microbiome Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 53 U.S.: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 54 U.S.: Market Size, By Application, 2022–2025 (USD Million)
Table 55 U.S.: Size, By Disease, 2022–2025 (USD Million)
Table 56 U.S.: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 57 U.S.: Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 58 U.S.: Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 59 U.S.: Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 60 Canada: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 61 Canada : Market Size, By Application, 2022–2025 (USD Million)
Table 62 Canada : Size, By Disease, 2022–2025 (USD Million)
Table 63 Canada: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 64 Canada: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 65 Canada: Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 66 Canada: Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 67 Europe: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 68 Europe: Market Size, By Application, 2022–2025 (USD Million)
Table 69 Europe: Market Size, By Disease, 2022–2025 (USD Million)
Table 70 Europe: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 71 Europe: Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 72 Europe: Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 73 Europe: Human Microbiome Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 74 Asia-Pacific: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 75 Asia-Pacific: Market Size, By Application, 2020–2025 (USD Million)
Table 76 Asia-Pacific: Market Size, By Disease, 2022–2025 (USD Million)
Table 77 APAC: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million
Table 78 APAC: Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 79 APAC: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 80 APAC: Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 81 RoW: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 82 RoW: Market Size, By Application, 2022–2025 (USD Million)
Table 83 RoW: Market Size, By Disease, 2022–2025 (USD Million)
Table 84 RoW: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 85 RoW: Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 86 RoW: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 87 RoW: Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 88 Agreements, Partnerships, and Collaborations, 2013–2016
Table 89 Expansions, 2013–2016
Table 90 Product Launches and Approvals, 2013–2016
Table 91 Other Developments, 2013–2016


List of Figures (30 Figures)

Figure 1 Human Microbiome: Market Segmentation
Figure 2 Human Microbiome Research Spending: Market Segmentation
Figure 3 Research Design
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 7 Probiotics Segment to Dominate the Market During the Forecast Period
Figure 8 Consumables Segment to Witness the Highest Growth Rate in the Microbiome Research Spending Market From 2016 to 2021
Figure 9 Cell Culture Technologies to Dominate the Human Microbiome Research Spending Market in 2015
Figure 10 Geographical Snapshot of the Global Market, 2022
Figure 11 Growing Prevalence of Lifestyle Diseases and Increasing Acceptance of Microbiome-Based Products are Major Growth Drivers
Figure 12 Probiotics Segment Dominated the Human Microbiome Market in 2022
Figure 13 North America Accounted for the Largest Share of the Market in 2022-2025
Figure 14 North America to Grow at the Highest CAGR During the Forecast Period
Figure 15 Developed Regions to Grow at Higher CAGRs From 2022 to 2025
Figure 16 Cell Culture Technology Segment Dominated the Human Microbiome Research Spending Market in 2015
Figure 17 Market Drivers, Restraints, Opportunities, and Challenges
Figure 18 Funds Provided for Microbiome Research By Various Medical Research Agencies
Figure 19 Probiotics Segment to Command the Largest Share of the Human Microbiome Product Market By 2025
Figure 20 The Therapeutics Segment to Command the Largest Share of the Human Microbiome Applications Market By 2025
Figure 21 Acute Diarrhea Expected to Be the Largest Disease Segment of the Market in 2022
Figure 22 Geographic Snapshot (2022): North America Will Be the Fastest-Growing Region By 2022
Figure 23 North America to Grow at the Fastest Rate in the Human Microbiome Product Market From 2022 to 2025
Figure 24 Europe: Human Microbiome Market Snapshot
Figure 25 Companies Adopted Agreements, Collaborations, and Partnerships as the Key Growth Strategy Over the Last Three Years
Figure 26 Battle for Market Share: Agreements, Collaborations, and Partnerships are Key Growth Strategies for Market Players
Figure 27 Geographic Revenue Mix of Top 3 Market Players
Figure 28 E.I. Du Pont De Nemours and Company: Company Snapshot (2015)
Figure 29 Merck & Co., Inc.: Company Snapshot (2015)
Figure 30 Yakult Honsha Co., Ltd.: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 2711
Published ON
Mar, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Human Microbiome Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved